
Mitsui & Co., one of the most diversified and comprehensive trading, investment, and service enterprises in the world (with 140 offices in 66 countries) and BioAmber’s partner in the Sarnia bio-based succinic acid plant, is investing an additional CDN$ 25 million in the joint venture for 10% of the equity, increasing its stake from 30% to 40%. Mitsui will also play a stronger role in the commercialization of bio-succinic acid produced in Sarnia, providing dedicated resources alongside BioAmber’s commercial team. BioAmber will maintain a 60% controlling stake in the joint venture.








